up home page bottom

French German version Spanish version Italian version

header image

category archive listing Article Directory:

  1. #
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. X
  26. Y
  27. Z

September 12, 2008 – 9:52 pm
Posted by H. Sandra Chevalier-Batik

FDA Consumer Update addressing recent, questions about the safety of Gardasil, a HPV-vaccine that prevents infection with types of human papillomavirus (HPV) that cause most cases of cervical cancer and genital warts, and some vulvar and vaginal cancers.

$2.1B Swine Flu Vaccination Serum Windfall for Glaxo

July 23, 2009 – 10:27 am
Posted by H. Sandra Chevalier-Batik

Analysts note that the pandemic couldn’t have come at a better time for Glaxo, one of the world’s largest vaccine makers. Generics have been steadily eating into the company’s margins, leaving Glaxo looking for new products to make up the shortfall.

‘Abortion Drug’ Awaits New Political Treatment

June 16, 2008 – 10:24 am
Posted by H. Sandra Chevalier-Batik

With more research, it could offer new treatments for breast cancer, fibroids and endometriosis.
But since it’s an abortion drug, since it weathered a congressional investigation two years ago–and since it’s in short supply–researchers have yet to test its full potential.
That, says Amy Allina, program director of the Washington-based National Women’s Health Network, is the story [...]

2 Curas Contra El Cancer, 1 Vacuna y 1 Vitamina.

February 9, 2009 – 11:21 am
Posted by H. Sandra Chevalier-Batik

En este pequeño documento intento que la gente conozca la vacuna que inventaron en México, en la UNAM, que cura las lesiones papilomatosas incluso cuando son cancerosas, es decir, cura el cáncer concomitante al papilomavirus (HPV o por sus siglas en castellano: PVH).

También quiero que se corra el velo sobre una verdad oculta: la carencia de la vitamina b17 es causa de cáncer, y su ingesta, la cura.

25% of U.S. Girls, Young Women Ages 14 to 19 Have Common STI

March 12, 2008 – 10:25 am
Posted by H. Sandra Chevalier-Batik

DAILY WOMEN’S HEALTH POLICY REPORT PUBLIC HEALTH & EDUCATION
About 25% of U.S. girls and young women ages 14 to 19 have at least one of four common sexually transmitted infections, according to a study released Tuesday by CDC during a conference in Chicago, the New York Times reports. According to the Times, the study was [...]

2008 Was Not a Good Year for Merck

January 2, 2009 – 8:15 am
Posted by H. Sandra Chevalier-Batik

The forth quarter earning reports, the report card for publicly held companies, held no good news for Merck or its stockholders. Merck released its not overly optimistic guidance for 2009 that forecasted earnings and revenue below that expected by Wall Street analysts. It is never a good to disappoint ‘the street.’ Merck named lower sales of its Vytorin and Zetia cholesterol pills, sold as part of a joint venture with Schering-Plough as one reason for declining profit.

2009 Clinical Trials Predictions and Resolutions

December 12, 2008 – 1:58 pm
Posted by H. Sandra Chevalier-Batik

The nation’s ongoing economic turmoil is also threatening the pharmaceutical industry with “unfamiliar challenges,” says Ronald Waife, president of Needham, Mass.-based clinical research consultancy Waife & Associates. Long discovery and product cycles have traditionally shielded pharmaceutical companies from the realities of layoffs and facility shutdowns that they’re now being forced to confront.